Clinical Trials Browser

Phase 2/3 × Unknown × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03229616 2017-10-12

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Phase 2/3 Unknown

122 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02871869 2017-07-17

Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

Phase 2/3 Unknown

316 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse